- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
Medical cannabis organization expresses concern about Senator Jeff Sessions’ drug enforcement policy plans
Washington, DC — Today, confirmation hearings began for attorney general nominee, Senator Jeff Sessions. During the hearing, Sessions was questioned about medical marijuana by Senators Patrick Leahy and Mike Lee. Sessions implied that he would enforce current federal marijuana laws. Earlier in the hearing, Sessions said he would advise President Trump not to set policies that would conflict with federal law. While Sessions’ response did not explicitly state he would shut down state marijuana programs, his response to Senator Lee was, “the United States Congress has made the possession of marijuana in every state and the distribution of it an illegal act,” and that, “it’s not so much the Attorney General’s job to decide what laws to enforce. We should do our jobs and enforce laws as effectively as we are able.” Sessions concluded that Congress must change the law if they do not want the Attorney General to prosecute marijuana crimes.
In response, Americans for Safe Access, released the following statement:
“The vague answers given by Senator Jeff Sessions during today's Attorney General confirmation hearing provided little comfort for the 2 million American patients who rely on state-run medical cannabis programs to provide them with physician-recommended medicine. Each of the 44 states that have medical cannabis programs, including 15 states with patient access to CBD, such as Sessions home state of Alabama, technically violate federal law.
“While it is encouraging the President-Elect Trump's incoming press secretary has said Sessions will abide by Trump's position on medical cannabis, Sessions has yet to make such a commitment to respect state medical cannabis laws. With that said, Sessions still has an opportunity to set the record straight and pledge that he will respect medical cannabis patients and the state programs upon which they rely. Similarly, Congress can put the issue to rest by passing legislation to respect state medical laws.”
# # #